Growing community of inventors

Yunnan, China

Baomin Fan

Average Co-Inventor Count = 7.27

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Baomin FanZhaoxiang Bian (4 patents)Baomin FanChengyuan Lin (4 patents)Baomin FanAiping Lu (3 patents)Baomin FanYongyun Zhou (3 patents)Baomin FanAlbert Sun-Chi Chan (2 patents)Baomin FanHuaixue Mu (2 patents)Baomin FanJingchao Chen (2 patents)Baomin FanAlbert Sun Chi Chan (1 patent)Baomin FanJun Wang (1 patent)Baomin FanQingjing Yang (1 patent)Baomin FanWeimin Zeng (1 patent)Baomin FanChao Huang (1 patent)Baomin FanJianbin Xu (1 patent)Baomin FanJun Hu (1 patent)Baomin FanBaomin Fan (4 patents)Zhaoxiang BianZhaoxiang Bian (19 patents)Chengyuan LinChengyuan Lin (10 patents)Aiping LuAiping Lu (15 patents)Yongyun ZhouYongyun Zhou (3 patents)Albert Sun-Chi ChanAlbert Sun-Chi Chan (14 patents)Huaixue MuHuaixue Mu (5 patents)Jingchao ChenJingchao Chen (2 patents)Albert Sun Chi ChanAlbert Sun Chi Chan (7 patents)Jun WangJun Wang (4 patents)Qingjing YangQingjing Yang (2 patents)Weimin ZengWeimin Zeng (1 patent)Chao HuangChao Huang (1 patent)Jianbin XuJianbin Xu (1 patent)Jun HuJun Hu (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Hong Kong Baptist University (4 from 125 patents)

2. Yunnan Minzu University (2 from 3 patents)

3. Yunnan University of Nationalities (1 from 1 patent)


4 patents:

1. 10040740 - Method for the preparation of iodoalkanes

2. 9783519 - Palladium/silver co-catalyzed tandem reactions synthesis of phenylacetophenone derivatives by oxabenzonorbornadienes with terminal alkynes and their anti-tumor or anti-cancer activities

3. 9120816 - Oxanorbornadiene derivatives and their anticancer activities

4. 8835658 - Asymmetric synthesis of norcantharidin analougus by alkynylation of oxabenzonorbornadienes and their anticancer activities

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/12/2025
Loading…